613 related articles for article (PubMed ID: 20965891)
1. Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France.
Descamps D; Chaix ML; Montes B; Pakianather S; Charpentier C; Storto A; Barin F; Dos Santos G; Krivine A; Delaugerre C; Izopet J; Marcelin AG; Maillard A; Morand-Joubert L; Pallier C; Plantier JC; Tamalet C; Cottalorda J; Desbois D; Calvez V; Brun-Vezinet F; Masquelier B; Costagliola D;
J Antimicrob Chemother; 2010 Dec; 65(12):2620-7. PubMed ID: 20965891
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of drug resistance mutations in Spain among both naive and pretreated patients.
Soriano V
Antivir Ther; 1999; 4 Suppl 3():57-63. PubMed ID: 16021872
[TBL] [Abstract][Full Text] [Related]
3. Evidence of differential selection of HIV-1 variants carrying drug-resistant mutations in seroconverters.
Corvasce S; Violin M; Romano L; Razzolini F; Vicenti I; Galli A; Duca P; Caramma I; Balotta C; Zazzi M
Antivir Ther; 2006; 11(3):329-34. PubMed ID: 16759049
[TBL] [Abstract][Full Text] [Related]
4. HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.
Aulicino PC; Rocco CA; Mecikovsky D; Bologna R; Mangano A; Sen L
Antivir Ther; 2010; 15(4):641-50. PubMed ID: 20587857
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of drug resistance and newly recognised treatment-related substitutions in the HIV-1 reverse transcriptase and protease genes from HIV-positive patients naïve for anti-retrovirals.
Torti C; Bono L; Gargiulo F; Uccelli MC; Quiros-Roldan E; Patroni A; Paraninfo G; Tirelli V; Manca N; De Francesco MA; Perandin F; Carosi G
Clin Microbiol Infect; 2004 Sep; 10(9):826-30. PubMed ID: 15355414
[TBL] [Abstract][Full Text] [Related]
6. Analysis of drug resistance-associated mutations in treatment-naïve individuals infected with different genetic forms of HIV-1 circulating in countries of the former Soviet Union.
Vázquez de Parga E; Rakhmanova A; Pérez-Alvarez L; Vinogradova A; Delgado E; Thomson MM; Casado G; Sierra M; Muñoz M; Carmona R; Vega Y; Contreras G; Medrano L; Osmanov S; Nájera R
J Med Virol; 2005 Nov; 77(3):337-44. PubMed ID: 16173024
[TBL] [Abstract][Full Text] [Related]
7. Frequency of protease and reverse transcriptase drug resistance mutations in naïve HIV-infected patients.
Valle-Bahena OM; Ramos-Jiménez J; Ortiz-López R; Revol A; Lugo-Trampe A; Barrera-Saldaña HA; Rojas-Martínez A
Arch Med Res; 2006 Nov; 37(8):1022-7. PubMed ID: 17045121
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral drug resistance among HIV-1 infected children failing treatment.
Mullen J; Leech S; O'Shea S; Chrystie IL; Du Mont G; Ball C; Sharland M; Cottam F; Zuckerman M; Rice P; Easterbrook P
J Med Virol; 2002 Nov; 68(3):299-304. PubMed ID: 12226814
[TBL] [Abstract][Full Text] [Related]
9. Drug resistance in non-subtype B HIV-1.
Kantor R; Katzenstein D
J Clin Virol; 2004 Mar; 29(3):152-9. PubMed ID: 14962783
[TBL] [Abstract][Full Text] [Related]
10. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.
de Mulder M; Yebra G; Martín L; Prieto L; Mellado MJ; Rojo P; Muñoz-Fernández MÁ; Jiménez de Ory S; Ramos JT; Holguín A;
J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of antiretroviral drug resistance among HIV-1-untreated patients in Guinea-Conakry and in Niger.
Charpentier C; Bellecave P; Cisse M; Mamadou S; Diakite M; Peytavin G; Tchiombiano S; Teisseire P; Pizarro L; Storto A; Brun-Vézinet F; Katlama C; Calvez V; Marcelin AG; Masquelier B; Descamps D
Antivir Ther; 2011; 16(3):429-33. PubMed ID: 21555827
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolution.
Kantor R; Katzenstein D
AIDS Rev; 2003; 5(1):25-35. PubMed ID: 12875105
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece.
Paraskevis D; Magiorkinis E; Katsoulidou A; Hatzitheodorou E; Antoniadou A; Papadopoulos A; Poulakou G; Paparizos V; Botsi C; Stavrianeas N; Lelekis M; Chini M; Gargalianos P; Magafas N; Lazanas M; Chryssos G; Petrikkos G; Panos G; Kordossis T; Theodoridou M; Sypsa V; Hatzakis A;
Virus Res; 2005 Sep; 112(1-2):115-22. PubMed ID: 16022906
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of transmitted antiretroviral resistance and distribution of HIV-1 subtypes among patients with recent infection in Catalonia (Spain) between 2003 and 2005.
Romero A; Sued O; Puig T; Esteve A; Pumarola T; Casabona J; González V; Matas L; Tural C; Rodrigo I; Margall N; Domingo P; Casanova A; Ferrer E; Caballero E; Ribera E; Farré J; Puig T; Amengual MJ; Navarro G; Prat JM; Masabeu A; Simó JM; Villaverde CA; Barrufet P; Sauca MG; Ortin X; Ortí A; Navarro R; Euras JM; Vilaró J; Villà MC; Montull S; Vilanova C; Pujol F; Díaz O; Miró JM;
Enferm Infecc Microbiol Clin; 2011; 29(7):482-9. PubMed ID: 21543135
[TBL] [Abstract][Full Text] [Related]
15. The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities.
Weinstock HS; Zaidi I; Heneine W; Bennett D; Garcia-Lerma JG; Douglas JM; LaLota M; Dickinson G; Schwarcz S; Torian L; Wendell D; Paul S; Goza GA; Ruiz J; Boyett B; Kaplan JE
J Infect Dis; 2004 Jun; 189(12):2174-80. PubMed ID: 15181563
[TBL] [Abstract][Full Text] [Related]
16. Primary drug resistance in antiretroviral-naïve injection drug users.
Tossonian HK; Raffa JD; Grebely J; Viljoen M; Mead A; Khara M; McLean M; Krishnamurthy A; DeVlaming S; Conway B
Int J Infect Dis; 2009 Sep; 13(5):577-83. PubMed ID: 19111493
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors.
Bracciale L; Colafigli M; Zazzi M; Corsi P; Meraviglia P; Micheli V; Maserati R; Gianotti N; Penco G; Setti M; Di Giambenedetto S; Butini L; Vivarelli A; Trezzi M; De Luca A
J Antimicrob Chemother; 2009 Sep; 64(3):607-15. PubMed ID: 19608581
[TBL] [Abstract][Full Text] [Related]
18. Drug-resistance mutations in antiretroviral-naïve patients with established HIV-1 infection in Mexico.
Escoto-Delgadillo M; Vázquez-Valls E; Ramírez-Rodríguez M; Corona-Nakamura A; Amaya-Tapia G; Quintero-Pérez N; Panduro-Cerda A; Torres-Mendoza BM
HIV Med; 2005 Nov; 6(6):403-9. PubMed ID: 16268822
[TBL] [Abstract][Full Text] [Related]
19. High rate multiple drug resistances in HIV-infected patients failing nonnucleoside reverse transcriptase inhibitor regimens in Thailand, where subtype A/E is predominant.
Chetchotisakd P; Anunnatsiri S; Kiertiburanakul S; Sutthent R; Anekthananon T; Bowonwatanuwong C; Kowadisaiburana B; Supparatpinyo K; Horsakulthai M; Chasombat S; Ruxrungtham K;
J Int Assoc Physicians AIDS Care (Chic); 2006 Dec; 5(4):152-6. PubMed ID: 17101807
[TBL] [Abstract][Full Text] [Related]
20. Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations.
Monno L; Appice A; Cavaliere R; Scarabaggio T; Angarano G
J Infect Dis; 1999 Aug; 180(2):568-71. PubMed ID: 10395885
[No Abstract] [Full Text] [Related]
[Next] [New Search]
